FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LIXIVAPTAN
异名/同义词3'-CHLORO-5-FLUORO-4'-(5H-PYRROLO(2,1-C)(1,4)BENZODIAZEPIN-10(11H)-YLCARBONYL)-O-TOLUANILIDE
BENZAMIDE, N-(3-CHLORO-4-(5H-PYRROLO(2,1-C)(1,4)BENZODIAZEPIN-10(11H)-YLCARBONYL)PHENYL)-5-FLUORO-2-METHYL-
CRTX080
CRTX-080
LIXAR
LIXIVAPTAN
LIXIVAPTAN [INN]
LIXIVAPTAN [MART.]
LIXIVAPTAN [MI]
LIXIVAPTAN [USAN]
LIXIVAPTAN [VANDF]
LIXIVAPTAN [WHO-DD]
VPA985
VPA-985
WAY-VPA-985
CAS登记号168079-32-1
物质唯一标识(Unique Ingredient Identifier)8F5X4B082E
分子式C27H21ClFN3O2
国际化合物标识(International Chemical Identifier,InChI)PPHTXRNHTVLQED-UHFFFAOYSA-N
SMILESN1(C(c2c(cc(NC(c3c(ccc(c3)F)C)=O)cc2)Cl)=O)c4c(Cn5c(C1)ccc5)cccc4
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System